BACKGROUND: Complex I of the electron transport chain (ETC) is a possible target of volatile anesthetics (VAs). Complex I enzymatic activities are inhibited by VAs, and dysfunction of complex I can lead to hypersensitivity to VAs in worms and in people. Mutant analysis in Caenorhabditis (C.) elegans suggests that VAs may specifically interfere with complex I function at the binding site for its substrate ubiquinone. We hypothesized that isoflurane inhibits electron transport by competing with ubiquinone for binding to complex I. METHODS: Wildtype and mutant C. elegans were used to study the effects of isoflurane on isolated mitochondria. Enzymatic activities of the ETC were assayed and dose-response curves determined using established techniques. Two-dimensional native gels of mitochondrial proteins were performed after exposure of mitochondria to isoflurane. RESULTS: Complex I is the most sensitive component of the ETC to isoflurane inhibition; however, the proximal portion of complex I (the flavoprotein) is relatively insensitive to isoflurane. Isoflurane and quinone do not compete for a common binding site on complex I. The absolute rate of complex I enzymatic activity in vitro does not predict immobilization of the animal by isoflurane. Isoflurane had no measurable effect on stability of mitochondrial supercomplexes. Reduction of ubiquinone by complex I displayed positive cooperative kinetics not disrupted by isoflurane. CONCLUSIONS: Isoflurane directly inhibits complex I at a site distal to the flavoprotein subcomplex. However, we have excluded our original hypothesis that isoflurane and ubiquinone compete for a common hydrophobic binding site on complex I. In addition, immobilization of the nematode by isoflurane is not due to limiting absolute amounts of complex I electron transport as measured in isolated mitochondria.
BACKGROUND: Complex I of the electron transport chain (ETC) is a possible target of volatile anesthetics (VAs). Complex I enzymatic activities are inhibited by VAs, and dysfunction of complex I can lead to hypersensitivity to VAs in worms and in people. Mutant analysis in Caenorhabditis (C.) elegans suggests that VAs may specifically interfere with complex I function at the binding site for its substrate ubiquinone. We hypothesized that isoflurane inhibits electron transport by competing with ubiquinone for binding to complex I. METHODS: Wildtype and mutant C. elegans were used to study the effects of isoflurane on isolated mitochondria. Enzymatic activities of the ETC were assayed and dose-response curves determined using established techniques. Two-dimensional native gels of mitochondrial proteins were performed after exposure of mitochondria to isoflurane. RESULTS: Complex I is the most sensitive component of the ETC to isoflurane inhibition; however, the proximal portion of complex I (the flavoprotein) is relatively insensitive to isoflurane. Isoflurane and quinone do not compete for a common binding site on complex I. The absolute rate of complex I enzymatic activity in vitro does not predict immobilization of the animal by isoflurane. Isoflurane had no measurable effect on stability of mitochondrial supercomplexes. Reduction of ubiquinone by complex I displayed positive cooperative kinetics not disrupted by isoflurane. CONCLUSIONS:Isoflurane directly inhibits complex I at a site distal to the flavoprotein subcomplex. However, we have excluded our original hypothesis that isoflurane and ubiquinone compete for a common hydrophobic binding site on complex I. In addition, immobilization of the nematode by isoflurane is not due to limiting absolute amounts of complex I electron transport as measured in isolated mitochondria.
Authors: Marni J Falk; Julie R Rosenjack; Erzsebet Polyak; Wichit Suthammarak; Zhongxue Chen; Phil G Morgan; Margaret M Sedensky Journal: PLoS One Date: 2009-08-12 Impact factor: 3.240
Authors: Zoya V Niatsetskaya; Sergei A Sosunov; Dzmitry Matsiukevich; Irina V Utkina-Sosunova; Veniamin I Ratner; Anatoly A Starkov; Vadim S Ten Journal: J Neurosci Date: 2012-02-29 Impact factor: 6.167
Authors: Pavel I Zimin; Christian B Woods; Albert Quintana; Jan-Marino Ramirez; Philip G Morgan; Margaret M Sedensky Journal: Curr Biol Date: 2016-08-04 Impact factor: 10.834
Authors: Suzanne Roelofs; Ganesh R Manjeri; Peter H Willems; Gert Jan Scheffer; Jan A Smeitink; Jacques J Driessen Journal: J Anesth Date: 2014-02-13 Impact factor: 2.078
Authors: Charles William Carspecken; Sirisak Chanprasert; Franck Kalume; Margaret M Sedensky; Philip G Morgan Journal: Anesthesiology Date: 2018-10 Impact factor: 7.892
Authors: Renjini Ramadasan-Nair; Jessica Hui; Leslie S Itsara; Philip G Morgan; Margaret M Sedensky Journal: Anesthesiology Date: 2019-03 Impact factor: 7.892
Authors: Leah K Cambal; Andrew C Weitz; Hui-Hua Li; Yang Zhang; Xi Zheng; Linda L Pearce; Jim Peterson Journal: Chem Res Toxicol Date: 2013-04-19 Impact factor: 3.739